This funding supports investigator-initiated phase I clinical trials for diagnostic and therapeutic interventions addressing heart, lung, blood, and sleep disorders in adults and children. Trials may be single or multisite, requiring applicants to have regulatory approvals and trial readiness established by award time. The focus is on rapid trial initiation within the first quarter of the project period.
Eligible applicants include a wide range of organizations such as public housing authorities, tribal governments, nonprofits, state and local governments, small businesses, and institutions of higher education. Specific eligibility details are provided in the full announcement.
